The DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.
The role of cathepsins in osteoporosis and arthritis: Rationale for the design of new therapeutics
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
Neer, R. M., Arnaud, C. D., Zanchetta, J. R., Prince, R., Gaich, G. A., Reginster, J.-Y., Hodsman, A. B., Eriksen, E. F., Ish-Shalom, S., Genant, H. K., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105103441904 · Cited by 4,602
A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells
Black, R. A., Rauch, C. T., Kozlosky, C. J., Peschon, J. J., Slack, J. L., Wolfson, M. F., Castner, B. J., Stocking, K. L., Reddy, P., Srinivasan, S., et al. (1997) · Nature · doi:10.1038/385729a0 · Cited by 3,149
Estrogen Resistance Caused by a Mutation in the Estrogen-Receptor Gene in a Man
Smith, E. P., Boyd, J., Frank, G. R., Takahashi, H., Cohen, R. M., Specker, B., Williams, T. C., Lubahn, D. B., & Korach, K. S. (1994) · New England Journal of Medicine · doi:10.1056/nejm199410203311604 · Cited by 2,471
Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α
Moss, M. L., Jin, S.-L. C., Milla, M. E., Burkhart, W., Carter, H. L., Chen, W.-J., Clay, W. C., Didsbury, J. R., Hassler, D., Hoffman, C. R., et al. (1997) · Nature · doi:10.1038/385733a0 · Cited by 1,378
Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
Saag, K. G., Emkey, R., Schnitzer, T. J., Brown, J. P., Hawkins, F., Goemaere, S., Thamsborg, G., Liberman, U. A., Delmas, P. D., Malice, M.-P., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807303390502 · Cited by 1,258
The mechanism of action of aspirin
Vane, J. R., & Botting, R. M. (2003) · Thrombosis Research · doi:10.1016/s0049-3848(03)00379-7 · Cited by 1,225
Proteoglycans: many forms and many functions
Hardingham, T. E., & Fosang, A. J. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.3.1740236 · Cited by 1,195
Pycnodysostosis, a Lysosomal Disease Caused by Cathepsin K Deficiency
Gelb, B. D., Shi, G.-P., Chapman, H. A., & Desnick, R. J. (1996) · Science · doi:10.1126/science.273.5279.1236 · Cited by 1,029
The role of cytokines in osteoarthritis pathophysiology
Fernandes, J. C., Martel‐Pelletier, J., & Pelletier, J. (2002) · Biorheology: The Official Journal of the International Society of Biorheology · doi:10.1177/0006355x2002039001002025 · Cited by 1,015
Epidemiology and genetics of rheumatoid arthritis.
Silman, A. J., & Pearson, J. E. (2002) · Arthritis Research · doi:10.1186/ar578 · Cited by 985
Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice
Saftig, P., Hunziker, E., Wehmeyer, O., Jones, S., Boyde, A., Rommerskirch, W., Moritz, J. D., Schu, P., & von Figura, K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13453 · Cited by 913
Coxibs and Cardiovascular Disease
FitzGerald, G. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmp048288 · Cited by 899
Protease Inhibitors: Current Status and Future Prospects
Leung, D., Abbenante, G., & Fairlie, D. P. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990412m · Cited by 883
Cysteine Proteases and Their Inhibitors
Otto, H.-H., & Schirmeister, T. (1997) · Chemical Reviews · doi:10.1021/cr950025u · Cited by 759
NEW EMBO MEMBERS' REVIEW: Lysosomal cysteine proteases: facts and opportunities
Turk, V. (2001) · The EMBO Journal · doi:10.1093/emboj/20.17.4629 · Cited by 756
Cathepsin K, but Not Cathepsins B, L, or S, Is Abundantly Expressed in Human Osteoclasts
Drake, F. H., Dodds, R. A., James, I. E., Connor, J. R., Debouck, C., Richardson, S., Lee-Rykaczewski, E., Coleman, L., Rieman, D., Barthlow, R., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.21.12511 · Cited by 720
Purification and Cloning of Aggrecanase-1: A Member of the ADAMTS Family of Proteins
Tortorella, M. D., Burn, T. C., Pratta, M. A., Abbaszade, I., Hollis, J. M., Liu, R., Rosenfeld, S. A., Copeland, R. A., Decicco, C. P., Wynn, R., et al. (1999) · Science · doi:10.1126/science.284.5420.1664 · Cited by 686
Cathepsin L: Critical Role in Ii Degradation and CD4 T Cell Selection in the Thymus
Nakagawa, T., Roth, W., Wong, P., Nelson, A., Farr, A., Deussing, J., Villadangos, J. A., Ploegh, H., Peters, C., & Rudensky, A. Y. (1998) · Science · doi:10.1126/science.280.5362.450 · Cited by 674
Sukhova, G. K., Shi, G. P., Simon, D. I., Chapman, H. A., & Libby, P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci181 · Cited by 665
The Collagenolytic Activity of Cathepsin K Is Unique among Mammalian Proteinases
Garnero, P., Borel, O., Byrjalsen, I., Ferreras, M., Drake, F. H., McQueney, M. S., Foged, N. T., Delmas, P. D., & Delaissé, J.-M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.48.32347 · Cited by 644
Hollander, A. P., Heathfield, T. F., Webber, C., Iwata, Y., Bourne, R., Rorabeck, C., & Poole, A. R. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117156 · Cited by 611
Riese, R. J., Wolf, P. R., Brömme, D., Natkin, L. R., Villadangos, J. A., Ploegh, H. L., & Chapman, H. A. (1996) · Immunity · doi:10.1016/s1074-7613(00)80249-6 · Cited by 535
Cathepsin S Required for Normal MHC Class II Peptide Loading and Germinal Center Development
Shi, G.-P., Villadangos, J. A., Dranoff, G., Small, C., Gu, L., Haley, K. J., Riese, R., Ploegh, H. L., & Chapman, H. A. (1999) · Immunity · doi:10.1016/s1074-7613(00)80020-5 · Cited by 524
Lecaille, F., Kaleta, J., & Brömme, D. (2002) · Chemical Reviews · doi:10.1021/cr0101656 · Cited by 519
Self-citationVinyl Sulfones as Mechanism-Based Cysteine Protease Inhibitors
Palmer, J. T., Rasnick, D., Klaus, J. L., & Bromme, D. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00017a002 · Cited by 508
Self-citationCloning and Characterization of ADAMTS11 , an Aggrecanase from the ADAMTS Family
Abbaszade, I., Liu, R.-Q., Yang, F., Rosenfeld, S. A., Ross, O. H., Link, J. R., Ellis, D. M., Tortorella, M. D., Pratta, M. A., Hollis, J. M., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.33.23443 · Cited by 490
Leflunomide: mode of action in the treatment of rheumatoid arthritis
Breedveld, F. C., & Dayer, J.-M. (2000) · Annals of the Rheumatic Diseases · doi:10.1136/ard.59.11.841 · Cited by 485
Lark, M. W., Bayne, E. K., Flanagan, J., Harper, C. F., Hoerrner, L. A., Hutchinson, N. I., Singer, I. I., Donatelli, S. A., Weidner, J. R., Williams, H. R., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119526 · Cited by 470
Lysosomal cysteine proteases regulate antigen presentation
Honey, K., & Rudensky, A. Y. (2003) · Nature Reviews Immunology · doi:10.1038/nri1110 · Cited by 446
Mechanism of action of hydroxychloroquine as an antirheumatic drug
Fox, R. I. (1993) · Seminars in Arthritis and Rheumatism · doi:10.1016/s0049-0172(10)80012-5 · Cited by 430
Human Cathepsin O2, a Matrix Protein-degrading Cysteine Protease Expressed in Osteoclasts
Brömme, D., Okamoto, K., Wang, B. B., & Biroc, S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.4.2126 · Cited by 427
Molecular action of methotrexate in inflammatory diseases.
Chan, E. S. L., & Cronstein, B. N. (2002) · Arthritis Research · doi:10.1186/ar419 · Cited by 419
Nakagawa, T. Y., Brissette, W. H., Lira, P. D., Griffiths, R. J., Petrushova, N., Stock, J., McNeish, J. D., Eastman, S. E., Howard, E. D., Clarke, S. R. M., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80021-7 · Cited by 416
The Bone Lining Cell: Its Role in Cleaning Howship's Lacunae and Initiating Bone Formation
Everts, V., Delaissé, J. M., Korper, W., Jansen, D. C., Tigchelaar-Gutter, W., Saftig, P., & Beertsen, W. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.1.77 · Cited by 411
Cathepsin B1. A lysosomal enzyme that degrades native collagen
Burleigh, M. C., Barrett, A. J., & Lazarus, G. S. (1974) · Biochemical Journal · doi:10.1042/bj1370387 · Cited by 407
Invariant Chain Structure and MHC Class II Function
Cresswell, P. (1996) · Cell · doi:10.1016/s0092-8674(00)81025-9 · Cited by 380
Deficiency of cathepsin S reduces atherosclerosis in LDL receptor–deficient mice
Sukhova, G. K., Zhang, Y., Pan, J.-H., Wada, Y., Yamamoto, T., Naito, M., Kodama, T., Tsimikas, S., Witztum, J. L., Lu, M. L., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci14915 · Cited by 372
THE LYSOSOMAL CYSTEINE PROTEASES
McGrath, M. E. (1999) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.28.1.181 · Cited by 361
Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix
KAFIENAH, W., BRÖMME, D., BUTTLE, D. J., CROUCHER, L. J., & HOLLANDER, A. P. (1998) · Biochemical Journal · doi:10.1042/bj3310727 · Cited by 358
Molecular cloning of a possible cysteine proteinase predominantly expressed in osteoclasts.
Tezuka, K., Tezuka, Y., Maejima, A., Sato, T., Nemoto, K., Kamioka, H., Hakeda, Y., & Kumegawa, M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42227-7 · Cited by 341
Cathepsin S activity regulates antigen presentation and immunity.
Riese, R. J., Mitchell, R. N., Villadangos, J. A., Shi, G. P., Palmer, J. T., Karp, E. R., De Sanctis, G. T., Ploegh, H. L., & Chapman, H. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1158 · Cited by 321
Reddy, V. Y., Zhang, Q. Y., & Weiss, S. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.9.3849 · Cited by 318
Shi, G. P., Munger, J. S., Meara, J. P., Rich, D. H., & Chapman, H. A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42513-6 · Cited by 308
VI. Meta-Analysis of Calcitonin for the Treatment of Postmenopausal Osteoporosis
Cranney, A., Tugwell, P., Zytaruk, N., Robinson, V., Weaver, B., Shea, B., Wells, G., Adachi, J., Waldegger, L., Guyatt, G., et al. (2002) · Endocrine Reviews · doi:10.1210/er.2001-6002 · Cited by 286
Deussing, J., Roth, W., Saftig, P., Peters, C., Ploegh, H. L., & Villadangos, J. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4516 · Cited by 266
Brömme, D., & Okamoto, K. (1995) · Biological Chemistry Hoppe-Seyler · doi:10.1515/bchm3.1995.376.6.379 · Cited by 244
Regulation of Collagenase Activities of Human Cathepsins by Glycosaminoglycans
Li, Z., Yasuda, Y., Li, W., Bogyo, M., Katz, N., Gordon, R. E., Fields, G. B., & Brömme, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310349200 · Cited by 235
Self-citationProteases involved in MHC dass II antigen presentation
Villadangos, J. A., Bryant, R. A. R., Deussing, J., Driessen, C., Lennon‐Duménil, A., Riese, R. J., Roth, W., Saftig, P., Shi, G., Chapman, H. A., et al. (1999) · Immunological Reviews · doi:10.1111/j.1600-065x.1999.tb01360.x · Cited by 235
Shi, G.-P., Bryant, R. A. R., Riese, R., Verhelst, S., Driessen, C., Li, Z., Bromme, D., Ploegh, H. L., & Chapman, H. A. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.7.1177 · Cited by 235
Self-citationProteinases in bone resorption: obvious and less obvious roles
Delaissé, J.-M., Engsig, M. T., Everts, V., del Carmen Ovejero, M., Ferreras, M., Lund, L., Vu, T. H., Werb, Z., Winding, B., Lochter, A., et al. (2000) · Clinica Chimica Acta · doi:10.1016/s0009-8981(99)00230-2 · Cited by 227
Cysteine protease inhibitors as chemotherapy for parasitic infections
McKerrow, J. (1999) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(99)00008-5 · Cited by 224
Osteoarthritis: Is it a disease of cartilage or of bone?
Felson, D. T., & Neogi, T. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20051 · Cited by 223
Action of rat liver cathepsin L on collagen and other substrates.
Kirschke, H., Kembhavi, A. A., Bohley, P., & Barrett, A. J. (1982) · Biochemical Journal · doi:10.1042/bj2010367 · Cited by 222
The anti-inflammatory mechanism of sulfasalazine is related to adenosine release at inflamed sites
Gadangi, P., Longaker, M., Naime, D., Levin, R. I., Recht, P. A., Montesinos, M. C., Buckley, M. T., Carlin, G., & Cronstein, B. N. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.5.1937 · Cited by 196
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-813_7 · Cited by 193
Cathepsin K Is a Critical Protease in Synovial Fibroblast-Mediated Collagen Degradation
Hou, W.-S., Li, Z., Gordon, R. E., Chan, K., Klein, M. J., Levy, R., Keysser, M., Keyszer, G., & Brömme, D. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63068-4 · Cited by 190
Using inhibitors of metalloproteinases to treat arthritis. Easier said than done?
Vincenti, M. P., Clark, I. M., & Brinckerhoff, C. E. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370802 · Cited by 188
Proteolysis in MHC Class II Antigen Presentation
Villadangos, J. A., & Ploegh, H. L. (2000) · Immunity · doi:10.1016/s1074-7613(00)80176-4 · Cited by 183
Konttinen, Y. T., Mandelin, J., Li, T., Salo, J., Lassus, J., Liljeström, M., Hukkanen, M., Takagi, M., Virtanen, I., & Santavirta, S. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10185 · Cited by 182
Moldovan, F., Pelletier, J., Hambor, J., Cloutier, J. M., & Martel‐Pelletier, J. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400915 · Cited by 175
Collagenase Activity of Cathepsin K Depends on Complex Formation with Chondroitin Sulfate
Li, Z., Hou, W.-S., Escalante-Torres, C. R., Gelb, B. D., & Brömme, D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204004200 · Cited by 172
Brömme, D., Bonneau, P. R., Lachance, P., Wiederanders, B., Kirschke, H., Peters, C., Thomas, D. Y., Storer, A. C., & Vernet, T. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53472-4 · Cited by 169
Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity
Saegusa, K., Ishimaru, N., Yanagi, K., Arakaki, R., Ogawa, K., Saito, I., Katunuma, N., & Hayashi, Y. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14682 · Cited by 153
Stroup, G. B., Lark, M. W., Veber, D. F., Bhattacharyya, A., Blake, S. M., Dare, L. C., Erhard, K. F., Hoffman, S. J., James, I. E., Marquis, R. W., et al. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.10.1739 · Cited by 153
Accelerated Turnover of Metaphyseal Trabecular Bone in Mice Overexpressing Cathepsin K
Kiviranta, R., Morko, J. P., Uusitalo‐Järvinen, H., Aro, H. T., VUORIO, E. I., & Rantakokko, J. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.8.1444 · Cited by 147
Mörgelin, M., Paulsson, M., Hardingham, T., Heinegård, D. K., & Engel, J. (1988) · Biochemical Journal · doi:10.1042/bj2530175 · Cited by 144
Brömme, D., Klaus, J. L., Okamoto, K., Rasnick, D., & Palmer, J. T. (1996) · Biochemical Journal · doi:10.1042/bj3150085 · Cited by 140
Phagocytosis of bone collagen by osteoclasts in two cases of pycnodysostosis
Everts, V. E., Aronson, D. C., & Beertsen, W. (1985) · Calcified Tissue International · doi:10.1007/bf02557674 · Cited by 138
Greenspan, P. D., Clark, K., Tommasi, R., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010206q · Cited by 138
Leflunomide: A Review of its Use in Active Rheumatoid Arthritis
Prakash, A., & Jarvis, B. (1999) · Drugs · doi:10.2165/00003495-199958060-00010 · Cited by 135
Cathepsin K and the Design of Inhibitors of Cathepsin K
Yamashita, D. S., & Dodds, R. A. (2000) · Current Pharmaceutical Design · doi:10.2174/1381612003401569 · Cited by 135
Everts, V. E., Delaissé, J., Korper, W., & Beertsen, W. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.9.1420 · Cited by 134
Cytokine-induced cartilage proteoglycan degradation is mediated by aggrecanase
Arner, E. C., Hughes, C., Decicco, C. P., Caterson, B., & Tortorella, M. D. (1998) · Osteoarthritis and Cartilage · doi:10.1053/joca.1998.0114 · Cited by 132
Osteonecrosis of the maxilla in a patient with a history of bisphosphonate therapy.
Melo, M. D., & Obeid, G. (2005) · PubMed · Cited by 132
Novel, Nonpeptidic Cyanamides as Potent and Reversible Inhibitors of Human Cathepsins K and L
Falgueyret, J., Oballa, R. M., Okamoto, O., Wesolowski, G. A., Aubin, Y., Rydzewski, R. M., Prasit, P., Riendeau, D., Rodan, S. B., & Percival, M. D. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm0003440 · Cited by 129
Molecular mechanisms of neuroprotective action of immunosuppressants ‐ facts and hypotheses
Kaminska, B., Gawęda-Walerych, K., & Zawadzka, M. (2004) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2004.tb00259.x · Cited by 125
Kozacı, L. D., Buttle, D. J., & Hollander, A. P. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400121 · Cited by 122
Design of potent and selective human cathepsin K inhibitors that span the active site
Thompson, S. K., Halbert, S. M., Bossard, M. J., Tomaszek, T. A., Levy, M. A., Zhao, B., Smith, W. W., Abdel‐Meguid, S. S., Janson, C. A., D'Alessio, K. J., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14249 · Cited by 121
Katunuma, N., Murata, E., Kakegawa, H., et al. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01107-2 · Cited by 115
Goto, T. (2003) · Journal of Electron Microscopy · doi:10.1093/jmicro/52.6.551 · Cited by 113
Joint Destruction in Arthritis: Metalloproteinases the Spotlight
Brinckerhoff, C. (1991) · Arthritis & Rheumatism · doi:10.1002/art.1780340902 · Cited by 110
Osteoarthritis of the peripheral joints
Petersson, I. F., & Jacobsson, L. (2002) · Best Practice & Research Clinical Rheumatology · doi:10.1053/berh.2002.0266 · Cited by 104
Collagenase-1 and collagen in epidermal repair
Pilcher, B. K., Sudbeck, B. D., Dumin, J. A., Welgus, H. G., & Parks, W. C. (1998) · Archives of Dermatological Research · doi:10.1007/pl00007452 · Cited by 103
Zou, J., Rudwaleit, M., Brandt, J., Thiel, A., Braun, J., & Sieper, J. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10847 · Cited by 103
Azepanone-Based Inhibitors of Human and Rat Cathepsin K
Marquis, R. W., Ru, Y., LoCastro, S. M., Zeng, J., Yamashita, D. S., Oh, H.-J., Erhard, K. F., Davis, L. D., Tomaszek, T. A., Tew, D. G., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm000481x · Cited by 103
Mort, J. S., Magny, M., & Lee, E. R. (1998) · Biochemical Journal · doi:10.1042/bj3350491 · Cited by 99
Effects of the proteinase inhibitors leupeptin and E-64 on osteoclastic bone resorption
Everts, V. E., Beertsen, W., & Schröder, R. (1988) · Calcified Tissue International · doi:10.1007/bf02571316 · Cited by 98
Hou, W.-S., Li, Z., Büttner, F. H., et al. (2003) · Biological Chemistry · doi:10.1515/bc.2003.100 · Cited by 95
Everts, V. E., Hou, W.-S., Rialland, X., Tigchelaar, W., Säftig, P., Br�mme, D., Gelb, B. D., & Beertsen, W. (2003) · Calcified Tissue International · doi:10.1007/s00223-002-2092-4 · Cited by 92
Expression of Cathepsin K in Lung Epithelial Cells
Bühling, F., Gerber, A., Häckel, C., et al. (1999) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.20.4.3405 · Cited by 91
Cartilage proteoglycan aggregate is degraded more extensively by cathepsin L than by cathepsin B.
Nguyen, Q. K., Mort, J. S., & Roughley, P. J. (1990) · Europe PMC (PubMed Central) · Cited by 91
Thiol-Dependent Cathepsins: Pathophysiological Implications and Recent Advances in Inhibitor Design
Brömme, D., & Kaleta, J. (2002) · Current Pharmaceutical Design · doi:10.2174/1381612023394179 · Cited by 82
Self-citationLark, M. W., Stroup, G. B., James, I. E., et al. (2002) · Bone · doi:10.1016/s8756-3282(02)00675-0 · Cited by 78
Potts, W., Bowyer, J., Jones, H. B., Tucker, D. L., Freemont, A. J., Millest, A. J., Martin, C., Vernon, W., Neerunjun, D., Slynn, G., et al. (2004) · International Journal of Experimental Pathology · doi:10.1111/j.0959-9673.2004.00373.x · Cited by 75
Yasuma, T., Oi, S., Choh, N., et al. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9803065 · Cited by 75
Kirschke, H., Schmidt, I., & Wiederanders, B. (1986) · Biochemical Journal · doi:10.1042/bj2400455 · Cited by 74
Link protein as a monitor in situ of endogenous proteolysis in adult human articular cartilage
Nguyen, Q. K., Liu, J., Roughley, P. J., & Mort, J. S. (1991) · Biochemical Journal · doi:10.1042/bj2780143 · Cited by 69
Dendritic cells: The driving force behind autoimmunity in rheumatoid arthritis?
Pettit, A. R., & Thomas, R. (1999) · Immunology and Cell Biology · doi:10.1046/j.1440-1711.1999.00855.x · Cited by 67
Seyfried, D. M., Veyna, R. S., Han, Y., Li, K., Tang, N., Betts, R. L., Weinsheimer, S., Chopp, M., & Anagli, J. Y. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02289-2 · Cited by 56
Cyclic Ketone Inhibitors of the Cysteine Protease Cathepsin K
Marquis, R. W., Ru, Y., Zeng, J., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm000320t · Cited by 52
Aggrecan degradation in osteoarthritis and rheumatoid arthritis
Lark, M. W., Bayne, E. K., & Lohmander, S. L. (1995) · Acta Orthopaedica Scandinavica · doi:10.3109/17453679509157660 · Cited by 51
Abe, M., Kawamoto, K., Okamoto, H., & Horiuchi, N. (2001) · Journal of Periodontal Research · doi:10.1034/j.1600-0765.2001.360303.x · Cited by 50
[46] Peptidyl diazomethanes as inhibitors of cysteine and serine proteinases
Shaw, E. N. (1994) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(94)44048-4 · Cited by 43
THE ROLES OF CALCIUM AND VITAMIN D IN THE PREVENTION OF OSTEOPOROSIS
Reid, I. R. (1998) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70011-6 · Cited by 41
Leroy, V., & Thurairatnam, S. (2004) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.14.3.301 · Cited by 41
Katunuma, N., Matsui, A., Inubushi, T., et al. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1953 · Cited by 40
Katunuma, N., Tsuge, H., Nukatsuka, M., Asao, T., & Fukushima, M. (2002) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2709 · Cited by 37
The effects of fluoromethyl ketone inhibitors of cathepsin B on adjuvant induced arthritis.
Esser, R. E., Watts, L. M., Angelo, R., et al. (1993) · PubMed · Cited by 37
Potent and selective inactivation of cysteine proteinases with N-peptidyl-O-acyl hydroxylamines
Brömme, D., Schierhorn, A., Kirschke, H., et al. (1989) · Biochemical Journal · doi:10.1042/bj2630861 · Cited by 35
Potent and Selective Cathepsin L Inhibitors Do Not Inhibit Human Osteoclast Resorption in Vitro
James, I. E., Marquis, R. W., Blake, S. M., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010684200 · Cited by 32
Abramson, S. B. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10609 · Cited by 28
Metalloproteinase inhibitors as therapeutics.
Gordon, J. L., Drummond, A. H., & GALLOWAY, W. A. (1993) · PubMed · Cited by 28
Cohen, S. B. (2004) · Current Rheumatology Reports · doi:10.1007/s11926-004-0084-2 · Cited by 27
[48] N,O-Diacyl hydroxamates as selective and irreversible inhibitors of cysteine proteinases
Brömme, D., & Demuth, H. (1994) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(94)44050-6 · Cited by 22
Role of biologics in early arthritis.
Emery, P. E., & Seto, Y. (2004) · PubMed · Cited by 22
European and North American experience with HRT for the prevention of osteoporosis
Eriksen, E. F. (1996) · Bone · doi:10.1016/s8756-3282(96)90162-3 · Cited by 21
Osteoporosis: pathophysiology and non-pharmacological management
Mundy, G. R. (2001) · Best Practice & Research Clinical Rheumatology · doi:10.1053/berh.2001.0190 · Cited by 19
Umland, E. M., Rinaldi, C., Parks, S. M., & Boyce, E. G. (1999) · Annals of Pharmacotherapy · doi:10.1345/aph.18463 · Cited by 19
Cited by
Cysteine cathepsins: From structure, function and regulation to new frontiers
Turk, V., Stoka, V., Vasiljeva, O., Renko, M., Sun, T., Turk, B., & Turk, D. (2012) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2011.10.002 · Cited by 1,377
Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response
Olson, O. C., & Joyce, J. A. (2015) · Nature Reviews Cancer · doi:10.1038/nrc4027 · Cited by 699
Aging and bone loss: new insights for the clinician
Demontiero, O., Vidal, C., & Duque, G. (2012) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x11430858 · Cited by 559
Cysteine cathepsins: Cellular roadmap to different functions
Brix, K., Dunkhorst, A., Mayer, K., & Jordans, S. (2008) · Biochimie · doi:10.1016/j.biochi.2007.07.024 · Cited by 428
Choe, Y., Leonetti, F., Greenbaum, D. C., Lecaille, F., Bogyo, M., Brömme, D., Ellman, J. A., & Craik, C. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513331200 · Cited by 425
Metadata
- Authors
- YASUDA, Y., KALETA, J., & BROMME, D.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2005-05-25
- Volume
- 57
- Issue
- 7
- Pages
- 973-993
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W1989560280
- Cited by
- 300
- References
- 119
- FWCI
- 6.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.